Study of the Frame Platform to Support Women With Fertility Issues and Emotional Stress During Treatment, Ages 22 to 44

What this Trial Is About

Researchers are conducting a randomized, controlled pilot study to evaluate the impact of the FRAME platform on women experiencing fertility issues and emotional stress. This study will enroll approximately 400 women who have completed an initial consultation at participating fertility clinics. The purpose is to assess how the use of FRAME influences patient retention and emotional well-being during fertility care. Participants will be randomly assigned to one of two groups. The control group will receive no additional intervention and continue their usual fertility care for six months. The intervention group will have access to FRAME, a digital platform offering resources, education, and support from a dedicated care team, including board-certified fertility coaches. They are encouraged to use FRAME for six months alongside their fertility care. All participants will complete psychological questionnaires at enrollment and after six months, including measures like the Perceived Stress Scale, Personal Health Questionnaire Depression Scale, and Fertility Problem Stress Scale. Medical records will be reviewed for up to nine months post-enrollment to track fertility treatment initiation and timing. The primary outcome is whether fertility treatment starts within about six months, with secondary outcomes including the time to treatment start. This study also monitors participants emotional health and retention in fertility care.

Frame Support Study